跨膜蛋白质在恶性肿瘤中作用的研究进展

Research progress on the role of transmembrane proteins in malignant tumors

跨膜蛋白质(TMEMs)是一种横跨脂质生物膜的蛋白质家族,它作为生物膜上的通道蛋白质发挥着重要的生理作用。TMEMs在恶性肿瘤中表达上调促进恶性肿瘤进展,例如TMEM16A、TMEM206,也有表达下调促进恶性肿瘤发展的TMEM100,以及在不同恶性肿瘤的表达相反的TMEM98,可作为肿瘤的治疗靶点和预后标志物。此外,TMEMs通过不同上下游调控因子通过Wnt、AKT信号通路的发挥作用,以及在某些恶性肿瘤细胞中对顺铂相关化学耐药性有进一步的研究。

Transmembrane proteins(TMEMs)are a class of family proteins that span lipid bilayers,serving as crucial channel proteins on biological membranes,playing essential physiological roles.TMEMs′over-expression in malignant tumors,such as TMEM16A and TMEM206,has been linked to the promotion of malignancy.Conversely,down-regulation of TMEM100 expression has been associated with tumor progression.TMEM98,whose expression varies across different malignancies.TMEMs has shown promise as both a therapeutic target and a prognostic marker in cancer.Additionally,TMEMs play a vital role in various malignancies by modulating the Wnt and AKT signaling pathways through interaction with different upstream and downstream regulatory factors.Furthermore,research has provided additional insights into their role in cisplatin-related chemoresistance in specific malignant tumor cell populations.